PMID: 6969550Feb 1, 1980Paper

Aminoglycoside ototoxicity

American Journal of Otolaryngology
S A Lerner, G J Matz

Abstract

Aminoglycoside antibiotics are frequently employed in the treatment of serious infections caused by aerobic gram negative bacilli. The use of these potent antibacterial agents is limited by the risks of ototoxicity and nephrotoxicity. Aminoglycosides are excreted by glomerular filtration at a rate proportional to the serum concentration. Impaired renal excretion reduces the rate of clearance from the serum. Utilizing information about aminoglycoside pharmacokinetics, the susceptibility of infecting pathogens to aminoglycosides, and risk factors for ototoxicity, physicians can attempt to optimize the administratioin of an aminoglycoside to maximize the therapeutic efficacy and to minimize the risk of ototoxicity. Periodic assessments of renal function and of aminoglycoside levels in the serum are essential to guide therapy. The otolaryngologist and audiologist must be able to provide information about ototoxicity to medical colleagues using these drugs. They should also be prepared to evaluate and follow patients who develop sensorineural inner ear dysfunction during or after a course of therapy with an aminoglycoside antibiotic.

Citations

Jan 1, 1987·Archives of Oto-rhino-laryngology·L P Rybak
Mar 1, 1990·Hearing Research·C A ProsenJ E Hawkins
May 26, 2004·Hearing Research·Jennifer L HeydtMarc D Coltrera
Dec 4, 2003·International Journal of Pharmaceutics·Y V Rama PrasadKanji Takada
May 24, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yukako ItoKanji Takada
Feb 13, 2002·International Journal of Pharmaceutics·Zhaopeng HuKanji Takada
Apr 10, 2013·Asian Pacific Journal of Tropical Biomedicine·Mumuni Audu Momoh, Charles Okechukwu Esimone
Oct 7, 1993·The New England Journal of Medicine·J B Nadol
Feb 6, 1999·Critical Care Medicine·N A HalpernM Alicea
Jun 1, 1989·Antimicrobial Agents and Chemotherapy·R E Brummett, K E Fox
Mar 8, 2003·American Journal of Respiratory and Critical Care Medicine·Kelvin H-V TanAlan R Smyth
Nov 13, 2010·PloS One·David MannPaul Hoetjes
Apr 1, 1985·Postgraduate Medicine·J T Johnson, D B Kamerer
Feb 1, 1984·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·V G SchweitzerM Christy
Apr 14, 2006·Expert Opinion on Drug Safety·Joshua G YorgasonFederico Kalinec
Oct 21, 2003·Journal of Perinatology : Official Journal of the California Perinatal Association·Varsha Bhatt-Mehta, Steven M Donn
Apr 28, 2005·Chemotherapy·Carmelo Scarpignato, Iva Pelosini
Jul 21, 2005·Ultrastructural Pathology·Sarah KohnTheodore C Iancu
Apr 7, 2016·Ophthalmic Genetics·Madelon L GeurtsenCas Smits
Dec 29, 2020·Antimicrobial Agents and Chemotherapy·Elizabeth Story-RollerGyanu Lamichhane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.